A collaborative approach between scientific and regulatory actors with regard to statistical design, analysis, and methodological approaches is needed for building evidence for pharmaceutical, biologic and biosimilar, combination product and device development, and approval.
To support continuous learning, DIA brings you complimentary digital downloads to spur thought, reflection, collaboration, and action. In your Resource Kit, you'll find links to intriguing articles from the DIA Global Forum and our peer-reviewed journal, Therapeutic Innovation & Regulatory Science (TIRS), exclusive podcast interviews, session recordings from DIA events, and more!
Exclusive Session Recording from Biostats 2019:Challenges and Opportunities for Bayesian Methods in Confirmatory Setting
Adaptive and Patient-Centric Designs and MRCTs: Implications for Biostatisticians in China
The DIA Statistics Community: Getting the Questions Right Through Collaboration
Podcast: Statistical Strategies for Using Sources of Safety Data
Podcast: DIA Forum Acts on Statistical Impact of 21st Century Cures